Research

Research pipeline: from Himalayan medicinal plants to tested leads

Four early-stage programmes, each shown at the stage it has really reached.

Our approach

Early-stage and stated plainly: each programme shows where it really is today. BBCRI is a young company, so this page describes programmes and intentions, not results. We will report results here when we have them.

We start from what people already use. Traditional formulas point to plants worth studying; computational tools suggest which compounds might matter and what they might act on; partner laboratories test the short list. Read how the stages fit together on the Sowa-Omics™ platform page.

Programmes

Platform · In development

AI-enabled drug discovery

Use integrated omics and traditional-use evidence to prioritise natural-product leads, then test them with partner laboratories.

Chemistry · Exploratory

Natural products and medicinal plants

Characterise Bhutanese medicinal species chemically and genetically, with sustainable sourcing and cultivation in mind.

Products · Planned

Preventive wellness

Develop evidence-backed wellness products that respect Sowa Rigpa principles and meet modern quality standards.

Therapeutics · Exploratory

Therapeutic lead development

Carry the strongest natural-product candidates from Sowa-Omics™ into early preclinical studies with partner laboratories: confirming how they act, how potent they are and whether they are safe, starting with chronic conditions where Sowa Rigpa formulas have a long history of use.

Status labels mean what they say. "Exploratory" and "Planned" programmes have not started laboratory work.

Plants of interest

These species appear in the Sowa Rigpa materia medica and are examples of the kind of plant our research is concerned with. Listing a plant here is not a claim about what it does.

Responsible access and sourcing

Built around Bhutan's access and benefit-sharing framework and the Nagoya Protocol, crediting knowledge holders. Lawful access is a barrier competitors cannot easily cross.

Several Himalayan medicinal plants are under pressure from over-collection. Our natural-products programme is planned with sustainable sourcing and cultivation in mind.

Evidence before claims

Nothing is called a therapy until it is validated. That discipline is what partners, regulators and customers pay for.

Work with us

Co-design validation studies, share assay capacity, and supervise joint student projects in natural products and computational biology. See partnership options or meet the team.

Start a conversation.

Investors, partners and customers: tell us what you have in mind. We reply to every message.

Email ramesh@bbcri.online Invest or partner